Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · Real-Time Price · USD

0.4049

-0.0487 (-10.74%)

At close: Jun 9, 2026, 4:00 PM EDT

0.4097

+0.0048 (1.19%)

Pre-market: Jun 10, 2026, 6:00 AM EDT

Heron Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Heron Therapeutics stock have an average target of $2.00, which predicts a 393.95% increase from the current stock price of 0.4.

Price Target: $2.00 (+393.95%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$2.00	$2.00	$2.00
Change	+393.95%	+393.95%	+393.95%	+393.95%

Analyst Ratings

The average analyst rating for Heron Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	0	0	0	0	0	0
Buy	4	4	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes H.C. Wainwright	H.C. Wainwright	Buy Reiterates $4 → $2	Buy	Reiterates	$4 → $2	+393.95%	Jun 3, 2026
Serge Belanger Needham	Needham	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 2, 2026

Financial Forecast

Revenue This Year

165.65M

from 154.90M

6.94%

from 154.90M

Revenue Next Year

175.90M

from 165.65M

6.19%

from 165.65M

EPS This Year

-0.09

from -0.05

EPS Next Year

n/a

from -0.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	86.35M	107.67M	127.04M	144.29M	154.90M	165.65M
Revenue Growth	-2.59%	24.70%	17.99%	13.57%	7.36%	6.94%
Gross Profit	-89.30M	-25.71M	26.81M	88.95M	101.13M	121.17M
Gross Margin	-103.42%	-23.87%	21.10%	61.65%	65.28%	73.15%
Operating Income	-216.43M	-169.26M	-93.02M	-11.53M	-2.54M	-3.60M
Net Income	-220.68M	-182.02M	-110.56M	-13.58M	-20.20M	-12.35M
EPS	-	-	-	-	-0.05	-0.09
Free Cash Flow	-103.97M	-75.80M	-16.84M	-25.82M	-28.46M	38.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	173.1M
Avg	165.7M
Low	158.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	11.7%
Avg	6.9%
Low	2.1%

EPS Forecast

EPS	2026	2027	2028
High	-0.09
Avg	-0.09
Low	-0.09

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-